发现好书期刊，享受阅读乐趣

海量图书期刊资源，随时随地畅享阅读乐趣

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

Datko, F.M.; Dickler, M.N.

期刊名称Breast Diseases: A Year Book Quarterly
作者Datko, F.M.; Dickler, M.N.
卷第23卷
期第4期
印刷ISSN1043-321X
文件大小295.08KB
发表时间2012-1
DOI10.1016/j.breastdis.2012.10.001
页码375-376

← 返回【学霸图书馆】主页